Click to copy
Click to copy

Aduro Biotech: 2Q Earnings Snapshot

August 2, 2019

BERKELEY, Calif. (AP) _ Aduro Biotech Inc. (ADRO) on Thursday reported a loss of $18.6 million in its second quarter.

On a per-share basis, the Berkeley, California-based company said it had a loss of 23 cents.

The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 16 cents per share.

The drug developer posted revenue of $4.9 million in the period, topping Street forecasts. Four analysts surveyed by Zacks expected $4.6 million.

The company’s shares closed at $1.40. A year ago, they were trading at $5.40.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ADRO at https://www.zacks.com/ap/ADRO

All contents © copyright 2019 The Associated Press. All rights reserved.